79388822 - OPTIMAL TRACERS

Information

  • Trademark
  • 79388822
  • Serial Number
    79388822
  • Filing Date
    September 22, 2023
    2 years ago
  • Transaction Date
    July 27, 2025
    8 months ago
  • Status Date
    February 28, 2025
    a year ago
  • Location Date
    February 28, 2025
    a year ago
  • Status Code
    641
  • Current Location
    TMO LAW OFFICE 131
    Employee Name
    WATKINS, JONATHAN
  • Attorney Docket Number
    17113.211IB
    Attorney Name
    Andrew S. Ehard
    Law Office Assigned Location Code
    O40
  • Owners
Mark Drawing Code
4
Mark Identification
OPTIMAL TRACERS
Case File Statements
  • GS0401: Custom manufacture of pharmaceuticals, namely, radiopharmaceuticals; Custom manufacture of pharmaceuticals, namely, radiolabelling of pharmaceuticals
  • GS0051: Chemicals for pharmaceutical use in the nature of chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical drugs for the treatment of cancer and diseases associated with cellular proliferation; Pharmaceutical preparations for the treatment of cancer and diseases associated with cellular proliferation; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical products, namely, radiopharmaceutical diagnostic preparations and radiopharmaceutical treatment preparations for the treatment of cancer and diseases associated with cellular proliferation; chemicals for radiopharmaceuticals for diagnostic uses; radiopharmaceutical drugs for diagnostic uses; radiopharmaceutical preparations for diagnostic uses; radiopharmaceutical products for diagnostic uses; Radioactive pharmaceutical preparations for use in vivo diagnostic or therapeutic use; radioactive elements, isotopes, preparations and reagents for radioactive labelling of pharmaceutical products; Diagnostic radiopharmaceutical preparations
  • GS0351: Advertising services; business advisory services relating to product development; business consultancy; retail and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; intermediary business services relating to the commercialization of goods, namely, procuring of contracts for third parties for the purchase and sale of goods
  • GS0011: Radioactive elements for scientific purposes; radioactive preparations for scientific purposes; chemicals for use in the manufacture of radiopharmaceutical products; chemical products for radioactive labelling
  • GS0451: Exploitation of intellectual property rights, namely, licensing of intellectual property rights; licensing of intellectual property
  • GS0101: Apparatus for administering pharmaceuticals for the treatment, prevention, or diagnosis of cancer, namely, medical apparatus for introducing pharmaceutical preparations into the human body for the treatment, prevention, or diagnosis of cancer; apparatus for medical purposes for the treatment, prevention, or diagnosis of cancer, namely, injection needles, injection syringes, and radiological apparatus for the treatment, prevention, or diagnosis of cancer; medical apparatus for the treatment of cancer; diagnostic imaging apparatus for medical use; pharmaceutical instruments, namely, radiological apparatus for medical purposes, medical apparatus for the treatment of cancer and diseases associated with cellular proliferation, and imaging apparatus for medical use for diagnosing medical conditions; applicators for pharmaceutical preparations, namely, applicators for pharmaceutical preparations sold without medication
  • GS0421: Provision of scientific information in the field of pharmaceuticals and clinical trials; scientific and technical analysis, namely, scientific research analysis in the field of pharmaceuticals; scientific consultancy; scientific research; scientific research in the field of pharmacy; medical research; research and development of products; laboratory research relating to pharmaceuticals; advisory services being product development consultation relating to immunological products; research and development of new techniques for radiolabelling of pharmaceutical products
Case File Event Statements
  • 2/9/2024 - 2 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 2/12/2024 - 2 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 2/16/2024 - 2 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 3/14/2024 - 2 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 3/21/2024 - 2 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 4/9/2024 - a year ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 3/20/2024 - 2 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/9/2024 - a year ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 5/1/2024 - a year ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 10/7/2024 - a year ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/7/2024 - a year ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/7/2024 - a year ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/28/2025 - a year ago
    14 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/26/2025 - a year ago
    13 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/7/2025 - 8 months ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 7/7/2025 - 8 months ago
    16 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 7/26/2025 - 8 months ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 3/29/2025 - 12 months ago
    15 - REFUSAL PROCESSED BY IB Type: RFNT